GENEVA, Oct. 18 -- HSF PHARMACEUTICALS SA (Avenue de Sully 671814 La Tour-de-Peilz) filed a patent application (PCT/EP2025/059413) for "RECOMBINANT ALPHAHERPESVIRUS VECTORS" on Apr 07, 2025. With publication no. WO/2025/214935, the details related to the patent application was published on Oct 16, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): VOELLMY, Richard (Avenue de Sully 671814 La Tour-de-Peilz)
Abstract: Disclosed are novel recombinant alphaherpesviruses that comprise (a) a heat shock promoter that controls the expression of a first viral gene that is essential for the replication o...